Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements

Journal of Extra-Corporeal Technology

Volumn 39, Issue 2, 2007, Pages 66-70

  Wiefferink, Alice E C M ^a   Weerwind, Patrick W ^b,c   Van Heerde, Waander ^b   Teerenstra, Steven ^b   Noyez, Luc ^b   De Pauw, Ben E ^b   Brouwer, René M H J ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autotransfusion; Cardiopulmonary bypass; Cardiotomy suction; Coronary surgery; Fibrin degradation

Indexed keywords

D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CELL SUSPENSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; ERYTHROCYTE; FEMALE; FIBRINOLYSIS; HEMODILUTION; HUMAN; INTERVENTION STUDY; MALE; MEDIASTINUM; MONITORING; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TUBE; BLOOD CLOTTING; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PERIOPERATIVE PERIOD; PHYSIOLOGY; TIME;

AGED; BLOOD COAGULATION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIOPULMONARY BYPASS; CHEST TUBES; FEMALE; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD; TIME FACTORS;

EID: 35248900401     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: A review. Intensive Care Med. 2004;30:1873-81.
2. Weerwind PW, Lindhout T, Caberg NEH, De Jong DS. Thrombin generation during cardiopulmonary bypass: The possible role of retransfusion of blood aspirated from the surgical field. Thromb J. 2003;1:3.
3. Gunaydin S. Clinical significance of coated extracorporeal circuits: A review of novel technologies. Perfusion. 2004;19:S33-41.
4. Wan S, LeClerc J-L, Vincent J-L. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676-92.
5. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742-55.
6. Eisses MJ, Seidel K, Aldea GS, Chandler WL. Reducing hemostatic activation during cardiopulmonary bypass: A combined approach. Anesth Analg. 2004;98:1208-16.
7. De Somer F, Van Belleghem Y, Caes F, et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2002;123:951-8.
8. Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ. Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion. 2003;18:115-21.
9. Sirvinskas E, Lenkutis T, Raliene L, Veikutiene A, Vaskelyte J, Marchertiene I. Influence of residual blood autotransfused from cardiopulmonary bypass circuit on clinical outcome after cardiac surgery. Perfusion. 2005;20:71-5.
10. Teufelsbauer H, Proidl S, Havel M, Vukovish T. Early activation of hemostasis during cardiopulmonary bypass. Evidence for thrombin-mediated hyperfibrinolysis. Thromb Haemost. 1992;68:250-2.
11. Comunale ME, Carr JM, Moorman RM, Robertson LK. Significance of D-dimer concentrations during and after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1996;10:477-81.
12. Chandler WL, Velan T. Plasmin generation and D-dimer formation during cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2004;15:583-91.
13. Sidelmann JJ, Gram J, Jespersen J, Kluft C. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost. 2000;26:605-18.
14. Collen A, Koolwijk P, Kroon M, van Hinsbergh V. Influence of fibrin structure on the formation an maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis. 1998;2:153-65.
15. Emeis JJ. Mechanisms involved in short-term changes in blood levels of t-PA. In: Kluft C, ed. Tissue-Type Plasminogen Activator (t-PA): Physiological and Clinical Aspects, Vol 2. Boca Raton, FL: CRC Press; 1988: 22-31.
16. Oliver JJ, Webb DJ, Newby DE. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol. 2005;25:2470-9.
17. Parolari A, Colli S, Mussoni L, et al. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery. J Thorac Cardiovasc Surg. 2003;125:336-43.
18. Whitten CW, Greilich PE, Ivy R, Burkhardt D, Allison PM. D-dimer formation during cardiac and noncardiac thoracic surgery. Anesth Analg. 1999;88:1226-31.
19. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116:1233-9.
20. Cross MH. Autotransfusion in cardiac surgery. Perfusion. 2001;16:391-400.